Global Sarcoma Therapeutics Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Sarcoma Therapeutics Market was valued at $2.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.6% CAGR, to an estimated market size of $2.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global sarcoma therapeutics market comprises pharmaceutical and biological interventions specifically designed to treat soft tissue sarcomas and bone sarcomas (such as osteosarcoma and Ewing sarcoma). The scope includes targeted therapies, immunotherapies, and chemotherapy, while excluding general surgical hardware and broad-spectrum radiotherapy equipment not specific to oncological drug delivery.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Sarcoma Therapeutics Market in the period 2025-30:
- The market is experiencing a significant shift from conventional cytotoxic chemotherapy toward targeted therapies that address specific oncogenic mutations.
- The approval of engineered cell therapies, such as TCR-based treatments, is creating new high-value segments for advanced and metastatic disease.
- Increased utilization of genomic profiling and molecular diagnostics is enabling precision medicine approaches tailored to rare sarcoma subtypes.
- Rising adoption of orphan drug designations is providing regulatory and financial incentives for pharmaceutical companies to invest in rare oncology research.
- The integration of artificial intelligence in drug discovery is accelerating the identification of novel molecules for previously undruggable sarcoma targets.
- A growing focus on combination immunotherapy trials is aimed at improving survival rates in refractory and recurrent sarcoma cases.
- The concentration of care in specialized sarcoma centers is streamlining the delivery of complex multidisciplinary therapeutic regimens.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Targeted Therapy
- Chemotherapy
- Immunotherapy
- Other Therapies